PT  - JOURNAL ARTICLE
AU  - Mikhail Chushkin
AU  - Batarbek Maliev
AU  - Andrey Belevskiy
AU  - Natalia Meshcheryakova
AU  - Svetlana Bukhareva
AU  - Sergey Smerdin
TI  - Using SF-36 in assessment of quality of life in patients cured of pulmonary tuberculosis
DP  - 2011 Sep 01
TA  - European Respiratory Journal
PG  - p2591
VI  - 38
IP  - Suppl 55
4099  - http://erj.ersjournals.com/content/38/Suppl_55/p2591.short
4100  - http://erj.ersjournals.com/content/38/Suppl_55/p2591.full
SO  - Eur Respir J2011 Sep 01; 38
AB  - Tuberculosis remains a public health problem with significant annual impacts on morbidity and mortality. As efficiency of treatment has increased, the focus of tuberculosis management has shifted from the prevention of mortality to the avoidance of morbidity. The aim of the study was to evaluate the quality of life (QoL) in patients who had been treated for pulmonary tuberculosis.Methods: In consecutive fashion, QoL was studied in 152 persons at the age of 20-82 who were observed at the local dispensary and 36 healthy subjects for comparison. The SF-36 was used for assessment of QoL. Pulmonary function was studied by spirometry.Results: Pearson correlation coefficient between SF-36 components and FEV1% ranged from 0.12 to 0.39, p<0.05 but RE). Test-retest correlation ranged from 0,57 to 0,9 (all p<0.05 but RP). All SF-36 components for participants with treated pulmonary tuberculosis were worse in comparison with healthy subjects (p<0.05 for all but Body Pain).View this table:All SF-36 components were worse in patients with impaired pulmonary function (FEV1< 80%).Conclusions: Quality of life in patients with history of tuberculosis was worse than for healthy subjects. The main factor influencing quality of life was impaired pulmonary function.